Cocrystal Pharma, Inc. (COCP) income statement
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.95−0.02 (-2.05%)
Close on Nov 20, 2026Market cap $18.30MP/E –Yield –
Cocrystal Pharma, Inc. financial ratios
See a number that looks wrong?